CareDx (CDNA) Reports In-Line Q3 EPS
CareDx (NASDAQ: CDNA) reported Q3 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $53.4 million versus the consensus estimate of $53.01 million.
For earnings history and earnings-related data on CareDx (CDNA) click here.
